Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial-Reference-Cited by-同舟云学术

Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial

Published:2020-10 Issue:10 Volume:19 Page:814-825
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Mulleners Wim M,Kim Byung-Kun,Láinez Miguel J A,Lanteri-Minet Michel,Pozo-Rosich Patricia,Wang Shufang,Tockhorn-Heidenreich Antje,Aurora Sheena K,Nichols Russell M,Yunes-Medina Laura,Detke Holland C

Publisher

Elsevier BV

Subject

Clinical Neurology

Reference30 articles.

1. The International Classification of Headache Disorders, 3rd edn;Cephalalgia,2018

2. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017;James;Lancet,2018

3. Factors associated with a history of failure and switching migraine prophylaxis treatment: an analysis of clinical practice data from the United States, Germany, France, and Japan;Pike;Value Health,2016

4. Adherence to oral migraine-preventive medications among patients with chronic migraine;Hepp;Cephalalgia,2015

5. Patterns of use and reasons for discontinuation of prophylactic medications for episodic migraine and chronic migraine: results from the second international burden of migraine study (IBMS-II);Blumenfeld;Headache,2013

Cited by 177 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. International Headache Society Global Practice Recommendations for Preventive Pharmacological Treatment of Migraine;Cephalalgia;2024-09

2. Algorithmus zur medikamentösen Migräneprophylaxe;Schmerzmedizin;2024-07

3. A Risk-Difference Meta-Analysis for the Prophylactic Treatments of Chronic Migraine;Cureus;2024-06-16

4. Pharmacotherapy for osteoarthritis-related pain: current and emerging therapies;Expert Opinion on Pharmacotherapy;2024-06-12

5. Definition of refractory migraine and their evolution;Neurology and Clinical Neuroscience;2024-06-07